Adenovirus gene therapy for ovarian cancer.
Russell
Willie
W
D000256:Adenoviridae / Q000235:genetics* / Q000276:immunology / Q000502:physiology; D000818:Animals; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D005260:Female; D016158:Genes, p53 / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology / Q000502:physiology; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000628:therapy*; D051059:PTEN Phosphohydrolase; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism
C568771:CLMP protein, human; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D011991:Receptors, Virus; D025521:Tumor Suppressor Proteins; D010744:Phosphoric Monoester Hydrolases; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human